Showing 41 - 60 results of 27,132 for search '(( 19 a decrease ) OR ( 50 ((((mg decrease) OR (greater decrease))) OR (mean decrease)) ))', query time: 0.59s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46

    Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  7. 47

    Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

    Published 2022
    “…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”
  8. 48
  9. 49
  10. 50
  11. 51

    Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

    Published 2024
    “…Overall, participants reported a medium stress level with an Extended Nursing Stress Scale (ENSS) mean score of 1.79 points, and 32.1% had occupational stress. …”
  12. 52

    Fig 2 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  13. 53

    Fig 3 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  14. 54
  15. 55
  16. 56

    Fig 4 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  17. 57

    Fig 1 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  18. 58
  19. 59
  20. 60